Why the IMWG Summit Is So Important

Submitted by blackswan on Fri, 05/24/2019 - 04:20

The 10th Annual International Myeloma Working Group (IMWG) Summit convenes in Amsterdam on June 10-12, 2019. Each year, the Summit hosts the top 100 or so myeloma researchers from around the world to focus on the major questions on the path to better therapies for myeloma and to find a cure. Researchers divide into work groups that develop actions plans for needed research and/or development of guidelines or recommendations. 

The Internaional Myeloma Working Group forges the path to precision myeloma care

Submitted by blackswan on Thu, 08/09/2018 - 12:30

Each patient with multiple myeloma is different. Within a myeloma support group, one can learn a lot about testing and treatments, but outcomes for individual patients are often very different. These differences must be studied in rigorously designed clinical trials to double-check test results and treatment details. So, while it might be tempting to compare what happened with Joe or Mary to yourself, the best guidance for your individual treatment is based on the best myeloma research, clinical trials, consensus statements, and guidelines. 

Bold Initiative Comes to Fruition: First Asian Myeloma Network Summit

Submitted by blackswan on Fri, 10/20/2017 - 02:51

This past weekend (October 13-15), the International Myeloma Foundation convened the first Asian Myeloma Network (AMN) Summit in Seoul, Korea. The seven countries/regions that make up the AMN – China, Hong Kong, Taiwan, Japan, Korea, Singapore, and Thailand – have worked collaboratively under the auspices of the IMF since 2011. With its structure modeled on the annual International Myeloma Working Group (IMWG) Summit, the Seoul meeting addressed a broad range of issues, examining the status in Asia of myeloma diagnosis, research, and treatment, as well as the next steps in implementing data-gathering and clinical trials in the region.  AMN members are clearly excited to be able to measure up to top US and European research groups, such as SWOG, ECOG, IFM, EMN, and the like. Expansion of myeloma research anywhere in the world has the potential to benefit myeloma patients everywhere.

University of California girds to combat cancer, a closer look at CAR-T cell therapy, and medical tourism to China—a wave of the future?

Submitted by blackswan on Thu, 09/14/2017 - 21:26

With new drug approvals and expanded indications for new myeloma drugs at an all-time high, there is a sense of optimism in the myeloma community. Yet, even as patients experience longer survival, myeloma remains very sneaky. The disease can evolve into resistant relapse phases, demanding new therapy.

Global Myeloma Voices Come Together to Drive Research and Improve Lives of Patients

Submitted by blackswan on Fri, 06/30/2017 - 02:55

Madrid BlogThis past week was very busy and important for the global myeloma community, which is increasingly coming together with a single voice for myeloma research and patient care. In Madrid, Spain, on the eve of the 2017 Congress of the European Hematology Association, the IMF provided platforms for many of these global research voices at the 2017 International Myeloma Working Group® (IMWG) Summit, as well as during the regular research update meeting of the IMF Black Swan Research Initiative® investigators team.

Pages